These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 31845730)
1. Efficacy of low-dose chemotherapy with methotrexate and vinblastine for patients with extra-abdominal desmoid-type fibromatosis: a systematic review. Shimizu K; Hamada S; Sakai T; Koike H; Yoshida M; Nishida Y Jpn J Clin Oncol; 2020 Apr; 50(4):419-424. PubMed ID: 31845730 [TBL] [Abstract][Full Text] [Related]
2. Effectiveness of doxorubicin-based and liposomal doxorubicin chemotherapies for patients with extra-abdominal desmoid-type fibromatosis: a systematic review. Shimizu K; Kawashima H; Kawai A; Yoshida M; Nishida Y Jpn J Clin Oncol; 2020 Oct; 50(11):1274-1281. PubMed ID: 32700733 [TBL] [Abstract][Full Text] [Related]
3. Therapy of desmoid tumors and fibromatosis using vinorelbine. Weiss AJ; Horowitz S; Lackman RD Am J Clin Oncol; 1999 Apr; 22(2):193-5. PubMed ID: 10199460 [TBL] [Abstract][Full Text] [Related]
4. Effective treatment of multifocal aggressive fibromatosis with low-dose chemotherapy. Caglar K; Ozyönüm H; Akalin M; Balci S Turk J Pediatr; 2006; 48(4):365-8. PubMed ID: 17290575 [TBL] [Abstract][Full Text] [Related]
5. Pazopanib or methotrexate-vinblastine combination chemotherapy in adult patients with progressive desmoid tumours (DESMOPAZ): a non-comparative, randomised, open-label, multicentre, phase 2 study. Toulmonde M; Pulido M; Ray-Coquard I; Andre T; Isambert N; Chevreau C; Penel N; Bompas E; Saada E; Bertucci F; Lebbe C; Le Cesne A; Soulie P; Piperno-Neumann S; Sweet S; Cecchi F; Hembrough T; Bellera C; Kind M; Crombe A; Lucchesi C; Le Loarer F; Blay JY; Italiano A Lancet Oncol; 2019 Sep; 20(9):1263-1272. PubMed ID: 31331699 [TBL] [Abstract][Full Text] [Related]
6. Long-term Efficacy of Methotrexate Plus Vinblastine/Vinorelbine in a Large Series of Patients Affected by Desmoid-Type Fibromatosis. Palassini E; Frezza AM; Mariani L; Lalli L; Colombo C; Fiore M; Messina A; Casale A; Morosi C; Collini P; Stacchiotti S; Casali PG; Gronchi A Cancer J; 2017; 23(2):86-91. PubMed ID: 28410293 [TBL] [Abstract][Full Text] [Related]
7. Low-dose chemotherapy with vinblastine and methotrexate in childhood desmoid tumors. Reich S; Overberg-Schmidt US; Bührer C; Henze G J Clin Oncol; 1999 Mar; 17(3):1086. PubMed ID: 10071306 [No Abstract] [Full Text] [Related]
8. [Low-dose methotrexate combined with vinorelbine for inoperable desmoid tumor: efficacy and the prognostic factors]. Fan Z; Li S; Fang Z; Liu J; Bai C; Xue R; Zhang L; Gao T Nan Fang Yi Ke Da Xue Xue Bao; 2016 Jan; 36(1):39-43. PubMed ID: 26806736 [TBL] [Abstract][Full Text] [Related]
9. Combination chemotherapy with methotrexate and vinblastine for surgically unresectable, aggressive fibromatosis. Park KH; Choi YJ; Kim KW; Ro KH; Kang CH; Song SH; Park JH Jpn J Clin Oncol; 2016 Sep; 46(9):845-9. PubMed ID: 27365524 [TBL] [Abstract][Full Text] [Related]
10. Successful low-dose chemotherapy using vinblastine and methotrexate for the treatment of an ileoanal pouch mesenteric desmoid tumor: report of a case. Kono T; Tomita I; Chisato N; Matsuda M; Kakisaka A; Kasai S Dis Colon Rectum; 2004 Feb; 47(2):246-9. PubMed ID: 15043298 [TBL] [Abstract][Full Text] [Related]
11. Clinical benefit of methotrexate plus vinorelbine chemotherapy for desmoid fibromatosis (DF) and correlation of treatment response with MRI. Ingley KM; Burtenshaw SM; Theobalds NC; White LM; Blackstein ME; Gladdy RA; Thipphavong S; Gupta AA Cancer Med; 2019 Sep; 8(11):5047-5057. PubMed ID: 31301110 [TBL] [Abstract][Full Text] [Related]
12. Is tumour location a prognostic factor for pharmacological treatment in patients with desmoid-type fibromatosis? a systematic review. Koike H; Hamada S; Sakai T; Shimizu K; Yoshida M; Nishida Y Jpn J Clin Oncol; 2020 Sep; 50(9):1032-1036. PubMed ID: 32533161 [TBL] [Abstract][Full Text] [Related]
13. Vinblastine and methotrexate for desmoid fibromatosis in children: results of a Pediatric Oncology Group Phase II Trial. Skapek SX; Ferguson WS; Granowetter L; Devidas M; Perez-Atayde AR; Dehner LP; Hoffer FA; Speights R; Gebhardt MC; Dahl GV; Grier HE; J Clin Oncol; 2007 Feb; 25(5):501-6. PubMed ID: 17290057 [TBL] [Abstract][Full Text] [Related]